ArticleInternational medical case reports journal2026
Malignant Transformation and Management of Cutaneous Squamous Cell Carcinoma in a 7-Year-Old Child with Xeroderma Pigmentosum: A Case Report from Somaliland.
Article in International medical case reports journal, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Introduction: Xeroderma pigmentosum (XP) is a rare autosomal recessive disorder characterized by defective DNA repair, leading to extreme photosensitivity Affected individuals have a profoundly elevated risk estimated to be more than 10,000-fold greater than the general population of developing cutaneous malignancies, primarily squamous cell carcinoma (SCC). Management requires rigorous photoprotection and prompt, often repeated, surgical excisions. This is critically challenging in resource-limited settings with high ultraviolet exposure and limited surgical/oncological infrastructure. Case Presentation: We report a 7-year-old female from rural Somaliland, born to consanguineous parents, She presented with a 6-month history of an ulcerated, bleeding plaque on her right temple. Two younger siblings also exhibited milder dermatological symptoms, raising suspicion of familial XP with a 2-year history of progressive photosensitivity, xerosis, and freckling. Examination revealed characteristic XP findings including diffuse poikiloderma and ocular involvement (conjunctival growths, dry eyes). A clinical diagnosis of XP with suspected SCC was made. The lesion was initially excised with a 2mm margin; however, the SCC recurred within three months. A second, more extensive wide local excision with a 4mm margin and flap reconstruction was successful. Histopathology confirmed well-differentiated SCC invading the deep dermis. Conclusion: This case highlights the aggressive and recurrent nature of cutaneous SCC in XP patients, It underscores the necessity of standard 4mm surgical margins even in anatomically challenging areas to prevent recurrence. Even in childhood. It underscores the immense challenges of managing this life-threatening genodermatosis in settings with limited access to specialized multidisciplinary care, advanced reconstructive surgery, and lifelong photoprotective resources. The iterative surgical approach, complicated by graft failure, illustrates the need for robust primary excision and highlights the role of pragmatic, adaptive surgical planning in low-resource contexts.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.